Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Clinical Trial
Official title:
A Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of the Treatment With Solriamfetol in Excessive Daytime Sleepiness (EDS) in Patients With Obstructive Sleep Apnea Syndrome (OSA) With a 12-week Treatment Period
The purpose of this study is to evaluate the efficacy and safety of 12-week solriamfetol administration in the treatment of EDS in patients with OSA from China, using a randomized, double-blind, placebo-controlled, multi-center, parallel-design.
n/a